| Tetracycline | Approved Investigational Vet Approved Withdrawn | WIPI1 | 55062 |
upregulated | Tetracycline results in increased expression of WIPI1 mRNA | 17q24.2 | |
| Levamisole | Approved Investigational Vet Approved Withdrawn | CLU | 1191 |
downregulated | Levamisole results in decreased expression of CLU mRNA | 8p21.1 | |
| Levamisole | Approved Investigational Vet Approved Withdrawn | EDN1 | 1906 |
downregulated | Levamisole results in decreased expression of EDN1 mRNA | 6p24.1 | |
| Levamisole | Approved Investigational Vet Approved Withdrawn | TP53 | 7157 |
downregulated | Levamisole results in decreased expression of TP53 mRNA | 17p13.1 | |
| Tetrathiomolybdate | Investigational | AGTR2 | 186 |
downregulated | tetrathiomolybdate analog results in decreased expression of AGTR2 mRNA | Xq23 | |
| Tetrathiomolybdate | Investigational | ANGPT2 | 285 |
upregulated | tetrathiomolybdate analog results in increased expression of ANGPT2 mRNA | 8p23.1 | |
| Tetrathiomolybdate | Investigational | AQP1 | 358 |
downregulated | tetrathiomolybdate analog results in decreased expression of AQP1 mRNA | 7p14.3 | |
| Tetrathiomolybdate | Investigational | BCL2 | 596 |
upregulated | tetrathiomolybdate analog results in increased expression of BCL2 mRNA | 18q21.33 | |
| Tetrathiomolybdate | Investigational | BCL2L2 | 599 |
upregulated | tetrathiomolybdate analog results in increased expression of BCL2L2 mRNA | 14q11.2 | |
| Tetrathiomolybdate | Investigational | CD40 | 958 |
upregulated | tetrathiomolybdate analog results in increased expression of CD40 mRNA | 20q13.12 | |
| Tetrathiomolybdate | Investigational | COX5B | 1329 |
upregulated | tetrathiomolybdate analog results in increased expression of COX5B mRNA | 2q11.2 | |
| Tetrathiomolybdate | Investigational | CRABP2 | 1382 |
downregulated | tetrathiomolybdate analog results in decreased expression of CRABP2 mRNA | 1q23.1 | |
| Tetrathiomolybdate | Investigational | CREBZF | 58487 |
upregulated | tetrathiomolybdate analog results in increased expression of CREBZF mRNA | 11q14.1 | |
| Tetrathiomolybdate | Investigational | CXCR4 | 7852 |
upregulated | tetrathiomolybdate analog results in increased expression of CXCR4 mRNA | 2q22.1 | |
| Tetrathiomolybdate | Investigational | GPX3 | 2878 |
upregulated | tetrathiomolybdate analog results in increased expression of GPX3 mRNA | 5q33.1 | |
| Tetrathiomolybdate | Investigational | GSR | 2936 |
upregulated | tetrathiomolybdate analog results in increased expression of GSR mRNA | 8p12 | |
| Tetrathiomolybdate | Investigational | HMOX1 | 3162 |
upregulated | tetrathiomolybdate analog results in increased expression of HMOX1 mRNA | 22q12.3 | |
| Tetrathiomolybdate | Investigational | IL2RA | 3559 |
downregulated | tetrathiomolybdate analog results in decreased expression of IL2RA mRNA | 10p15.1 | |
| Tetrathiomolybdate | Investigational | ITGB4 | 3691 |
downregulated | tetrathiomolybdate analog results in decreased expression of ITGB4 mRNA | 17q25.1 | |
| Tetrathiomolybdate | Investigational | JAG1 | 182 |
upregulated | tetrathiomolybdate analog results in increased expression of JAG1 mRNA | 20p12.2 | |
| Tetrathiomolybdate | Investigational | KLF2 | 10365 |
downregulated | tetrathiomolybdate analog results in decreased expression of KLF2 mRNA | 19p13.11 | |
| Tetrathiomolybdate | Investigational | PTGS2 | 5743 |
upregulated | tetrathiomolybdate analog results in increased expression of PTGS2 mRNA | 1q31.1 | |
| Tetrathiomolybdate | Investigational | SLC31A1 | 1317 |
upregulated | tetrathiomolybdate results in increased expression of SLC31A1 mRNA | 9q32 | |
| Tetrathiomolybdate | Investigational | SLC7A11 | 23657 |
upregulated | tetrathiomolybdate analog results in increased expression of SLC7A11 mRNA | 4q28.3 | |
| Tetrathiomolybdate | Investigational | SOD1 | 6647 |
downregulated | tetrathiomolybdate analog results in decreased expression of SOD1 mRNA | 21q22.11 | |